Yintoni enokuyenza ukuba igazi alikho lula ukujiya?


Umbhali: Ophumeleleyo   

Ubunzima bokudibanisa igazi bunokubangelwa yi-coagulation disorders, i-platelet abnormalities kunye nezinye izinto.Kucetyiswa ukuba izigulana zicoce inxeba kuqala, emva koko ziye esibhedlele ukuze zixilongwe kwangethuba.Ngokutsho kwesizathu, i-platelet transfusion, i-coagulation factor supplementation kunye nezinye iindlela zingenziwa phantsi kwesikhokelo sikagqirha.
1. Coca inxeba: Igazi akulula ukujija kwaye inxeba liya kuqhubeka ukopha.Isigulana kufuneka sihlambulule isilonda kuqala phantsi kwesikhokelo sikagqirha kwaye sisebenzise iodophor ukucoca isilonda ukuphepha usulelo lwebhaktheriya.
2. Utofelo-gazi lweplatelet: Ukuba igazi lomguli alidibanisi ngenxa yokubala kweplatelet ephantsi, utofelo-gazi lweplatelet lunokwenziwa phantsi kolwalathiso lukagqirha.Emva kotofelo-gazi, iimpawu zesigulana zifanele ziqwalaselwe ukuze kuphetshwe ezinye izinto ezinokubangela umonakalo kwimpilo yomguli.
3. Ukongezwa kweemeko ze-coagulation: Ukuba isigulane sibangelwa yi-coagulation dysfunction, sinokunyangwa nge-plasma kunye nokuxhaswa kwezinto ezidibeneyo phantsi kolwalathiso lukagqirha.
Ukongeza, kucetyiswa ukuba izigulana nazo zisebenzise amayeza e-antiviral ukuthintela usulelo njengoko beyalelwe ngugqirha wabo.Ukuba isigulane siziva singathandeki, kucetyiswa ukuba uye esibhedlele ukuze uhlolwe kwangethuba kwaye ujongane nayo ngokwesizathu phantsi kwesikhokelo sogqirha ukuphepha ukugula okunzulu kunye nokulimala kwimpilo yomguli.
I-Beijing SUCCEEDER njengenye yeebrendi eziphambili kwimarike ye-China Diagnostic ye-Thrombosis kunye ne-Hemostasis, i-SUCCEEDER inamava amaqela e-R&D, iMveliso, iNtengiso, iNtengiso yeNtengiso kunye noBonelelo lweNkonzo yokuHlalutya i-coagulation kunye ne-reagents, abahlalutyi begazi, i-ESR kunye nabahlalutyi be-HCT, i-platelet aggregation kunye ne-ISO1348 analyzer5 , Isiqinisekiso seCE kunye ne-FDA edwelisiweyo.